06826.HK
Shanghai Haohai Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 15.63
−2.68%Margins
Gross margin
64.0%
EBITDA margin
5.3%
EBIT margin
-2.1%
Net margin
4.5%
FCF margin
11.9%
1.9%
Return on equity
1.6%
Return on assets
-0.8%
Return on invested capital
0.35x
Asset turnover
HKD 559.4M
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026